Description: Conventional tests had failed to detect his father’s prostate cancer—but his “liquid biopsy” technology did. Source: Fast Company Date: April 1, 2016 When Santa Cruz professor Richard Otte, 61, got an annual screening test for prostate cancer, called a PSA, the results came back negative. Shortly thereafter, he reached out to his son Gabriel, an… Read more »